THNR vs. PPH ETF Comparison
Comparison of Amplify Weight Loss Drug & Treatment ETF (THNR) to Market Vectors Pharmaceutical ETF (PPH)
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$25.33
Average Daily Volume
2,814
15
PPH
Market Vectors Pharmaceutical ETF
PPH Description
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.Grade (RS Rating)
Last Trade
$91.39
Average Daily Volume
155,760
24
Performance
| Period | THNR | PPH |
|---|---|---|
| 30 Days | -4.66% | -2.80% |
| 60 Days | -10.17% | -7.69% |
| 90 Days | -2.39% | -2.54% |
| 12 Months | 21.69% |
THNR: Top Represented Industries & Keywords
PPH: Top Represented Industries & Keywords
Compare ETFs
